You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 13, Issue 5

May 2020 - 26 articles

Cover Story: COVID-19 (coronavirus disease 2019) is a worldwide outbreak of pneumonia and acute respiratory distress syndrome. Despite the fact that more than one thousand clinical trials have already been launched, no efficacious curative treatment is available to date. Although plasma therapy attracts much interest, the European clinical trial Discovery focuses on the potentialities of small molecules like remdesivir, the combination of lopinavir/ritonavir, hydroxychloroquine, and chloroquine. Partial reports are available but in-depth studies are still awaited with impatience. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (26)

  • Article
  • Open Access
17 Citations
4,509 Views
12 Pages

Anticancer Activity of Amb4269951, a Choline Transporter-Like Protein 1 Inhibitor, in Human Glioma Cells

  • Saiichiro Watanabe,
  • Nozomi Nishijima,
  • Kaho Hirai,
  • Kaoru Shibata,
  • Akane Hase,
  • Tsuyoshi Yamanaka and
  • Masato Inazu

Choline transporter-like protein 1 (CTL1) is highly expressed in glioma cells, and inhibition of CTL1 function induces apoptotic cell death. Therefore, CTL1 is a potential target molecule for glioma therapy. Here, we investigated the therapeutic mech...

  • Article
  • Open Access
13 Citations
14,425 Views
8 Pages

Constructing Auxin-Inducible Degron Mutants Using an All-in-One Vector

  • Aisha Yesbolatova,
  • Yuichiro Saito and
  • Masato T. Kanemaki

Conditional degron-based methods are powerful for studying protein function because a degron-fused protein can be rapidly and efficiently depleted by adding a defined ligand. Auxin-inducible degron (AID) is a popular technology by which a degron-fuse...

  • Communication
  • Open Access
21 Citations
4,103 Views
9 Pages

A Brief Report on an Implantation of Small-Caliber Biodegradable Vascular Grafts in a Carotid Artery of the Sheep

  • Larisa V. Antonova,
  • Andrey V. Mironov,
  • Arseniy E. Yuzhalin,
  • Evgeniya O. Krivkina,
  • Amin R. Shabaev,
  • Maria A. Rezvova,
  • Vadim O. Tkachenko,
  • Mariam Yu. Khanova,
  • Tatiana Yu. Sergeeva and
  • Sergei S. Krutitskiy
  • + 1 author

The development of novel biodegradable vascular grafts of a small diameter (<6 mm) is an unmet clinical need for patients requiring arterial replacement. Here we performed a pre-clinical study of new small-caliber biodegradable vascular grafts usi...

  • Communication
  • Open Access
11 Citations
8,811 Views
31 Pages

Background: The aim of this study was to assess the efficacy and safety of a new herbal preparation (Menopause Relief EP®), the hybrid combination of Actaea racemosa L. (black cohosh, BC) and Rhodiola rosea L. (RR) root extracts, compared with th...

  • Article
  • Open Access
28 Citations
4,511 Views
21 Pages

To understand the pathomechanism and pathophysiology of autosomal dominant sleep-related hypermotor epilepsy (ADSHE), we studied functional abnormalities of glutamatergic transmission in thalamocortical pathway from reticular thalamic nucleus (RTN),...

  • Article
  • Open Access
15 Citations
10,712 Views
24 Pages

Formulation and Evaluation of Loperamide HCl Oro Dispersible Tablets

  • Blasco Alejandro,
  • Torrado Guillermo and
  • Peña M Ángeles

This work proposes the design of novel oral disintegrating tablets (ODTs) of loperamide HCl with special emphasis on disintegration and dissolution studies. The main goal was augmenting the adherence to treatment of diseases which happen with diarrhe...

  • Review
  • Open Access
44 Citations
10,256 Views
29 Pages

The Rationale for Potential Pharmacotherapy of COVID-19

  • Maha Saber-Ayad,
  • Mohamed A. Saleh and
  • Eman Abu-Gharbieh

On 11 March 2020, the coronavirus disease (COVID-19) was defined by the World Health Organization as a pandemic. Severe acute respiratory syndrome-2 (SARS-CoV-2) is the newly evolving human coronavirus infection that causes COVID-19, and it first app...

  • Article
  • Open Access
29 Citations
4,790 Views
12 Pages

Mantonico and Pecorello Grape Seed Extracts: Chemical Characterization and Evaluation of In Vitro Wound-Healing and Anti-Inflammatory Activities

  • Gabriele Carullo,
  • Fabio Sciubba,
  • Paolo Governa,
  • Sarah Mazzotta,
  • Luca Frattaruolo,
  • Giorgio Grillo,
  • Anna Rita Cappello,
  • Giancarlo Cravotto,
  • Maria Enrica Di Cocco and
  • Francesca Aiello

The winemaking process produces a huge number of pomaces that generally are used for energy purposes. Further valuable applications such as health-promoting properties are still under investigation. The seeds of the white berries of Mantonico and Pec...

  • Opinion
  • Open Access
12 Citations
6,205 Views
9 Pages

Finding efficacious and safe treatments for COVID-19 emerges as a crucial need in order to control the spread of the pandemic. Whereas plasma therapy attracts much interest, the European project Discovery focuses on the potentialities of small molecu...

  • Article
  • Open Access
31 Citations
5,667 Views
18 Pages

Antiproliferative and Carbonic Anhydrase II Inhibitory Potential of Chemical Constituents from Lycium shawii and Aloe vera: Evidence from In Silico Target Fishing and In Vitro Testing

  • Najeeb Ur Rehman,
  • Sobia Ahsan Halim,
  • Majid Khan,
  • Hidayat Hussain,
  • Husain Yar Khan,
  • Ajmal Khan,
  • Ghulam Abbas,
  • Kashif Rafiq and
  • Ahmed Al-Harrasi

Lycium shawii Roem. & Schult and resin of Aloe vera (L.) BURM. F. are commonly used in Omani traditional medication against various ailments. Herein, their antiproliferative and antioxidant potential was explored. Bioassay-guided fractionation of...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247